Advanced Clinical Practice Fellowships

Expanding nurse practitioner scope of practice to improve heart failure medication optimization in an outpatient cardiac clinic

Summary

Over 600 000 Canadians are currently living with heart failure (HF), it is a progressive condition, characterized by high mortality rates, and frequent hospitalizations and readmissions (1). Despite being three years after the rise of coronavirus disease (COVID-19), the pandemic continues to cast its shadow on the healthcare system carrying unintended negative consequences on patient outcomes. A study conducted in Toronto demonstrated that early in pandemic there were fewer patient presentations to the emergency department with acute decompensated HF, however despite these trends there were higher HF in-hospital mortality rates (2). It is further suggested that likely the changes in patient care in response to public measures, as well as fear and inability to access care in a timely manner, may have led to additional heart failure deaths. (2). This signifies the importance of improving access to and the provision of timely evidence-based care and patient education in the outpatient settings. 

Our organization, Partners in Advanced Cardiac Evaluation (PACE Cardiology) is an outpatient cardiac clinic focused on research, diagnostics and delivery of evidence-based cardiac care. The organization is affiliated with major cardiac centers which allows a seamless transition between inpatient and outpatient worlds. Preliminary search conducted by our team identified a substantial number of patients with HFrEF who may be eligible for the medication optimization in the clinic (4). This signifies the clear need for an organized approach which would offer comprehensive care in evaluation, initiation and uptitration of guideline directed medical therapy (GDMT) which is considered to be the gold standard in HF management (2, 3).   

Early initiation of therapy as well as timely follow-up care after hospitalization is essential for overall improvement of outcomes, and can be achieved through regular medication optimization clinics (5). Nurse Practitioners with specialized knowledge and expertise in HF management are essential for the provision of comprehensive care for these patients.  As a team, we are launching a Nurse Practitioner (NP)-led HF medication optimization clinic, geared at initiation and optimization of GDMT. From this stemmed my need and motivation to further expand my competence and expertise in heart failure management, in order to actively participate in the medication optimization initiative. 

 

Through this fellowship, my goal was to develop and grow my clinical knowledge and expertise of the HF management, thereby to improve continuity of care and patient outcomes in an outpatient setting. After 4 months of intensive learning and clinical practice, not only was I able to achieve my goal, but also build a solid foundation for ongoing growth and learning in this area. 

My clinical experience took place at Southlake Regional Health Center, between three practice settings, including initial consults taking place in emergency department (ED), followed by an in-patient unit and an outpatient Heart Function Clinic. Choosing the hospital setting for my learning environment provided the opportunity to monitor and evaluate patient responses to therapy in real time, which was instrumental to solidifying my knowledge and understanding of the HF patient population, both in stable and acute decompensated states, as well as the role of medical management. 

I was able to enhance my knowledge base and skills in recognizing HF clinical manifestations and symptom presentation, including interpreting diagnostic tests and their significance to making diagnosis. I was able to fine tune and enhance my clinical assessment skills pertaining to cardiovascular assessments, particularly fluid volume status assessment. Specific focus was attributed to gaining an in-depth understanding of the GDMT, initiation of the therapy, up-titration process, and assessment of appropriateness of interventions. Moreover, I was able to gain a better understanding of the role of diuretic therapy for patients presenting with both acute decompensated heart failure and stable symptoms, as well as gain experience in initiating, monitoring and adjusting the dosage. Collaborating with and learning from the experts in HF management gave me an opportunity to challenge myself in a supported environment and apply the newfound knowledge of HF management when devising the care plans for patients. I was able to practice and further build my skill set in providing client education in HF disease progression, symptom recognition, medication compliance, and to support patients in gaining back their independence. This fellowship enriched my knowledge, confidence, clinical judgement and skills and prepared me to deliver comprehensive care and manage complex HF patients in the outpatient environment. 

Outcomes

The outcomes of this fellowship translated not only in my professional growth and ability to deliver safe and efficient evidence-based care, but also into patient outcomes. The primary patient population that I worked with during the fellowship and will continue to work with are adult patients diagnosed with Heart Failure, both with preserved and reduced ejection fraction. These patients can be in different stages of their illness trajectory, whether newly diagnosed, chronic or in decompensating state. 

            During patient interviewing, I was able to investigate and learn the frequent causes behind hospitalizations, readmissions and identify gaps and barriers to care in the outpatient setting. These include lack of understanding of disease progression and symptom recognition, inability to obtain timely appointments with primary HCP, as well as, most commonly, medication noncompliance, and progression of comorbidities. This invaluable knowledge guided my care and allowed me to address some of the aforementioned barriers through extensive patient education and referring patients to the appropriate community resources. Moreover, having the opportunity to follow patients from the ED to inpatient wards and into the outpatient Heart Function Clinic provided an invaluable experience of continuity of care for both patients and myself as the provider.  

The knowledge learned through this fellowship further emphasizes the importance of improving access to care and resources in the community settings. This supports the importance of NP-led HF medication optimization clinic at PACE cardiology. Through the clinics our organizational goal is to offer the holistic approach and ongoing support through frequent follow-ups and continuity of care to this vulnerable patient population. Expanding my Nurse Practitioner scope of practice, knowledge and expertise, has allowed me to actively participate in the medication optimization initiative, thereby improving access to timely care, offering safe, guideline-directed care to patients, and as a team taking efforts to prevent hospitalizations and ED readmissions.

The fellowship was an excellent networking platform which further strengthened the collaboration between PACE cardiology and SRHC cardiology Nurse Practitioner teams, solidifying the long-term collegial relationships built on mutual trust and respect.  This offered the opportunity to increase collaboration between the two centers, which was especially instrumental for establishing the continuity of patient care as they transition into the outpatient setting upon hospital discharge. Moreover, this also further defined the role of and the importance of conducting medication optimization clinics in the outpatient setting. 

Overall experience

Participating in the Advanced Clinical Practice Fellowship (ACPF) program provided me with the exciting opportunity to enhance my competence and professional practice in heart failure management. The fundamental learning experience gained through this fellowship allowed me to expand my scope of practice and to be actively involved in the NP-led medication optimization clinic initiative within our organization.

Immersing myself and learning in the in-patient environment offered me the necessary face-to-face interaction with patients and the members of the interprofessional team, which unfortunately is often lacking in the outpatient setting, where due to pandemic concerns many consultations occur virtually. Moreover, learning from and practicing alongside cardiologists and cardiology Nurse Practitioners who are experts in the Heart Failure management, was instrumental to my learning experience. Being able to discuss and review the cases not only stimulated my learning and critical thinking, but promoted understanding of the thought process behind the decision making and approaches to care taken by experts. 

Having the opportunity to transition between the inpatient and the outpatient realms, I was able to follow patients through different stages in their illness trajectory, which offered an invaluable insight into the complexities and intricacies of the heart failure syndrome. This included initial presentation to the emergency department, diagnostic work-up, devising care plans and monitoring the responses, and planning for and transitioning patients into the outpatient setting. This provided an excellent educational platform for me to further expand my knowledge and skills, and gain the valuable experience in continuity of care, building therapeutic relationships, counselling, and education. 

            With the successful completion of my fellowship and a breadth of new knowledge, I am excited to transition back to my role and to continue this learning journey in the outpatient practice setting. As for my fellow nursing colleagues, who are seeking to further expand ones knowledge and expertise in an effort to improve client care and outcomes in their practice settings, I strongly encourage them to participate in the ACPF program. 

 

References

(1) Buchan, T. A., Kugathasan, L., Kobulnik, J., Poon, S., Runeckles, K., Fan, S.,  Ross, H. J. (2022).Increased mortality in patients with acutely decompensated heart  failure during Covid-19 pandemic in Toronto, Canada. CJC Open. https://doi.org.10.1016/j.cjco.2022.06006

(2) Driscoll, A., Srivstava, P., Toia, D., Gibcus., J., & Hare, L. D. (2014). A nurse-led up-titration clinic improves chronic heart failure optimization of beta-adrenergic receptor blocking therapy – randomized controlled trial. BMC Research Notes, 7, 668

(3) Huitema, A. A., Daoust, A., Anderson, L., Poon, S., Virani, S., White, M., Rojas-Fernandez, C., Zieroth, S., McKelvie, R. S. (2020). Optimal usage of  sacubitril/valsartan for the Treatment of heart failure: the importance of optimizing heart failure care in Canada. CJC Open, 2, 321-327

(4) Pirbaglou, M., & Shamiss, Y. (2022). Medication Optimization 2022: screening protocols, patient resources & progress. [Power Point slides]. PACE Cardiology

 

(5) Waters, S. B., & Giblin, E. M. (2020). Acute heart failure: Pearls for the first posthospitalization clinic visit. Journal for Nurse Practitioners, 15 (1), 80-86